Sign In
Buy AGL
$91.61
-5.14 (-5.31%)
At Close: Jul 31, 2026
agilon health Sets Date to Report First Quarter 2023 Financial Results
04:21pm, Thursday, 20'th Apr 2023
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial res
agilon health: Strong Value Proposition In The Industry
12:55am, Thursday, 06'th Apr 2023
agilon health hosted its 2023 investor day, with positive updates on new health system partnerships and favorable updates to 2026 targets. Post the investor day, I have further conviction on AGL's val
agilon health Prospects Improve With Efficiency Gains
02:54pm, Friday, 03'rd Mar 2023
agilon health recently reported its Q4 2022 financial results. The firm provides value-based healthcare solutions to seniors in the United States.
agilon health, Inc. (AGL) Q4 2022 Earnings Call Transcript
10:45pm, Wednesday, 01'st Mar 2023
agilon health, Inc. (NYSE:AGL ) Q4 2022 Results Conference Call March 1, 2022 4:30 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participants S
Agilon Health (AGL) Reports Q4 Loss, Tops Revenue Estimates
06:48pm, Wednesday, 01'st Mar 2023
Agilon (AGL) delivered earnings and revenue surprises of -75% and 3.52%, respectively, for the quarter ended December 2022. Do the numbers hold clues to what lies ahead for the stock?
agilon health Sets Date to Report Fourth Quarter and Full Year 2022 Financial Results
04:30pm, Tuesday, 31'st Jan 2023
AUSTIN, Texas--( BUSINESS WIRE )--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial r
agilon health: Long-Term Sustainable Business Model To Address The Needs Of U.S. Healthcare
05:29am, Wednesday, 11'th Jan 2023
I believe the current US healthcare setup is not ideal for stakeholders. The agilon health platform offers a compelling value proposition to stakeholders.
agilon health: Back To Long-Term Range, Despite Underlying Market Growth
07:07pm, Wednesday, 14'th Dec 2022
agilon health, inc. is unable to return back to previous highs, losing support and buying volume. This, despite a reasonably strong quarter of growth.
This Dividend Stock Is Pouncing on a "Once-in-a-Generation" Opportunity
07:15am, Friday, 11'th Nov 2022
It's working toward speeding up the global transition to cleaner energy.
agilon health, inc. (AGL) Q3 2022 Earnings Call Transcript
07:19pm, Saturday, 05'th Nov 2022
agilon health, inc. (NYSE:AGL ) Q3 2022 Results Conference Call November 3, 2022 5:00 PM ET Company Participants Matthew Gillmor - VP, IR Steve Sell - CEO Tim Bensley - CFO Conference Call Participant
Agilon Health (AGL) Reports Q3 Loss, Tops Revenue Estimates
09:04pm, Thursday, 03'rd Nov 2022
Agilon (AGL) delivered earnings and revenue surprises of -40% and 6.70%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the stock?
agilon health Sets Date to Report Third Quarter 2022 Financial Results
04:15pm, Monday, 10'th Oct 2022
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health care in our communities, announced that it will release its financial res
agilon health to Participate in Upcoming Investor Conferences
04:15pm, Monday, 29'th Aug 2022
AUSTIN, Texas--(BUSINESS WIRE)--agilon health, inc. (NYSE: AGL), the trusted partner empowering physicians to transform health in our communities, announced that it will participate in the following i
agilon health, inc.'s (AGL) CEO Steve Sell on Q2 2022 Results - Earnings Call Transcript
12:05am, Saturday, 06'th Aug 2022
agilon health, inc. (NYSE:AGL ) Q2 2022 Earnings Conference Call August 4, 2022 5:00 PM ET Company Participants Matthew Gillmor – Vice President of Investor Relations Steve Sell – Chief Executive
agilon health Sets Stage For 2022 Growth
01:53pm, Monday, 23'rd May 2022
agilon health went public in April 2021, raising approximately $1 billion in an IPO. The firm provides health care services to Medicare Advantage patients in the United States.
